✦ LIBER ✦

Safety and Efficacy of ABT-089 in Pediatric Attention-Deficit/Hyperactivity Disorder: Results from Two Randomized Placebo-Controlled Clinical Trials

✍ Scribed by Wilens, Timothy E.; Gault, Laura M.; Childress, Ann; Kratochvil, Christopher J.; Bensman, Lindsey; Hall, Coleen M.; Olson, Evelyn; Robieson, Weining Z.; Garimella, Tushar S.; Abi-Saab, Walid M.; Apostol, George; Saltarelli, Mario D.

Book ID: 123438043
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 627 KB
Volume: 50
Category: Article
ISSN: 1527-5418
DOI: 10.1016/j.jaac.2010.10.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of reboxetine in adults with at

Efficacy of reboxetine in adults with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled clinical trial

✍ Forough Riahi; Mehdi Tehrani-Doost; Zahra Shahrivar; Javad Alaghband-Rad 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## Objective The main aim of this study is to evaluate the efficacy of reboxetine, a specific noradrenergic reuptake inhibitor, in adults with attention‐deficit/hyperactivity disorder (ADHD). ## Methods In a double blind placebo‐controlled clinical trial, the efficacy of 8 mg/day of

Efficacy and safety of the novel α4β2neu

Efficacy and safety of the novel α4β2neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study

✍ George Apostol; Walid Abi-Saab; Christopher J. Kratochvil; Lenard A. Adler; Wein 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 321 KB

Efficacy of lisdexamfetamine dimesylate

Efficacy of lisdexamfetamine dimesylate throughout the day in children and adolescents with attention-deficit/hyperactivity disorder: results from a randomized, controlled trial

✍ David R. Coghill, Tobias Banaschewski… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 333 KB

Predictors and impact of non-adherence i

Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial

✍ J J Sandra Kooij, Michael Rösler, Alexandra Philipsen, Sandra Wächter… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 209 KB

1082 – 40-week, randomized, double-blind

1082 – 40-week, randomized, double-blind, placebo-controlled, multicenter, efficacy and safety study of methylphenidate hydrochloride modified release (MPH-LA) in adults with attention deficit hyperactivity disorder (ADHD)

✍ Huss, M.; Ginsberg, Y.; Philipsen, A.; Tvedten, T.; Arngrim, T.; Greenbaum, M.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 17 KB

EPA-0672 – Efficacy outcomes in age and

EPA-0672 – Efficacy outcomes in age and sex subgroups from two clinical trials of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder

✍ Adler, L.A.; Dirks, B.; Adeyi, B.; Squires, L.A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 62 KB